Natasha Daughtrey

Amgen Files BPCIA Complaint Against Alkem Related To Denosumab Biosimilar

President Trump Issues Two Executive Orders Concerning The Affordability And Accessibility Of Drugs

Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR

Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.

Breaking: Judgment In Regeneron v. Mylan (Aflibercept) BPCIA Case Finding Some Claims Of Asserted Patents Valid And Infringed

REGENXBIO Sues Sarepta Therapeutics For Patent Infringement On Gene Therapy Product

Court Denies Motion For Preliminary Injunction In Biogen V. Sandoz Natalizumab BPCIA Litigation

FDA Approves Celltrion's YUFLYMA (adalimumab-aaty), A Biosimilar To HUMIRA

Alvotech Begins Confirmatory Study On EYLEA® Biosimilar

Challenges In Asserting The Advice Of Counsel Defense